| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $142.5M | -8.5% |
| Cost of Revenue | $86.9M | -8.8% |
| R&D Expense | $2.5M | -7.4% |
| SG&A Expense | $56.5M | -3.1% |
| Operating Income | -$5.5M | -145.5% |
| Pre-tax Income | -$3.3M | -456.2% |
| Income Tax | -$232K | -166.1% |
| Net Income | -$3.2M | -186.1% |
| EPS (Basic) | -$1.27 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.7M | +3.0% |
| Accounts Receivable | $24.0M | -13.9% |
| Inventory | $41.6M | +12.3% |
| Current Assets | $103.2M | +17.7% |
| Total Assets | $152.0M | +9.7% |
| Current Liabilities | $32.1M | +81.2% |
| Long-term Debt | $6.3M | -1.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.8M | +435.5% |
| Capital Expenditures | $1.9M | +81.8% |
| Investing Cash Flow | -$1.7M | -141.1% |
| Financing Cash Flow | -$2.4M | +11.0% |
| Free Cash Flow | $2.9M | +217.7% |
| -182.2% |
| EPS (Diluted) | -$1.27 | -182.2% |
| Total Liabilities |
| $42.6M |
| +45.3% |
| Stockholders' Equity | $91.6M | +0.6% |